Literature DB >> 15101712

Immunophenotypic analysis of hematogones (B-lymphocyte precursors) and neoplastic lymphoblasts by 4-color flow cytometry.

Robert W McKenna1, Sheryl L Asplund, Steven H Kroft.   

Abstract

Hematogones are identified by 4-color flow cytometry in most bone marrow specimens. They are more commonly found and are generally present in higher numbers in children. There is a general decline in hematogones with increasing age but a broad range exists at all ages and marrow from some adults contains relatively high numbers. They are often increased (> 5%) in regenerating marrow and in some clinical conditions, particularly various types of cytopenias and neoplastic diseases. Hematogones may morphologically resemble the neoplastic lymphoblasts of precursor B ALL and their immunophenotype also has features in common with neoplastic lymphoblasts. Distinguishing hematogones from neoplastic lymphoblasts may be problematic in post-chemotherapy and post-bone marrow transplant regenerating marrow. With 4-color flow cytometry using optimal antibody combinations the distinction can nearly always be made. Hematogone populations always exhibit a continuous and complete maturation spectrum of antigen expression typical of the normal evolution of B-lineage precursors; they lack aberrant or asynchronous antigen expression. The neoplastic lymphoblasts in precursor B ALL deviate from the normal B-lineage maturation spectrum and exhibit maturation arrest and over-, under-, and asynchronous expression of antigens observed on normal B-cell precursors and they often aberrantly express myeloid-associated antigens.

Entities:  

Mesh:

Year:  2004        PMID: 15101712     DOI: 10.1080/1042819031000151950

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  18 in total

1.  Transitional B cell subsets in human bone marrow.

Authors:  S Agrawal; S A B C Smith; S G Tangye; W A Sewell
Journal:  Clin Exp Immunol       Date:  2013-10       Impact factor: 4.330

Review 2.  Monitoring minimal/measurable residual disease in B-cell acute lymphoblastic leukemia by flow cytometry during targeted therapy.

Authors:  Zhiyu Liu; Yang Li; Ce Shi
Journal:  Int J Hematol       Date:  2021-01-27       Impact factor: 2.490

3.  In old BALB/c mice, bone marrow pre-B cell and surrogate light chain reduction is associated with increased B cell reactivity to phosphorylcholine, but reduced T15 idiotype dominance.

Authors:  Kelly Khomtchouk; Sarah Alter; Michelle Ratliff; Bonnie B Blomberg; Richard L Riley
Journal:  Mech Ageing Dev       Date:  2016-11-19       Impact factor: 5.432

4.  Bone marrow infiltration of CD20-negative follicular lymphoma after rituximab therapy: a histological mimicker of hematogones and B-cell acute lymphoblastic leukemia/lymphoma.

Authors:  Ikuo Matsuda; Seiichi Hirota
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

5.  Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma.

Authors:  Daisy Alapat; Jean Coviello-Malle; Rebecca Owens; Pingping Qu; Bart Barlogie; John D Shaughnessy; Robert B Lorsbach
Journal:  Am J Clin Pathol       Date:  2012-01       Impact factor: 2.493

6.  Impact of bone marrow hematogones on umbilical cord blood transplantation outcomes in patients with acute myeloid leukemia.

Authors:  Theodore Honebrink; Vanessa Dayton; Michael J Burke; Karen Larsen; Qing Cao; Claudio Brunstein; Daniel Weisdorf; Jeffery S Miller; John E Wagner; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2011-11-20       Impact factor: 5.742

7.  Detection of minimal residual disease in childhood B-acute lymphoblastic leukemia by 4-color flowcytometry.

Authors:  Ahmad Baraka; Laila M Sherief; Naglaa M Kamal; Shereen El Shorbagy
Journal:  Int J Hematol       Date:  2017-03-21       Impact factor: 2.490

8.  Quantification of marrow hematogones following autologous stem cell transplant in adult patients with plasma cell myeloma or diffuse large B-cell lymphoma and correlation with outcome.

Authors:  Victor Santiago; Aleksandr Lazaryan; Brian McClune; Robert W McKenna; Elizabeth L Courville
Journal:  Leuk Lymphoma       Date:  2017-07-21

9.  Abnormal B-cell maturation in the bone marrow of patients with germline mutations in PIK3CD.

Authors:  Alina E Dulau Florea; Raul C Braylan; Kristian T Schafernak; Kelli W Williams; Janine Daub; Rakesh K Goyal; Jennifer M Puck; V Koneti Rao; Stefania Pittaluga; Steven M Holland; Gulbu Uzel; Katherine R Calvo
Journal:  J Allergy Clin Immunol       Date:  2016-09-30       Impact factor: 10.793

10.  Hematogones: a sensitive prognostic factor for Chinese adult patients with acute myeloid leukemia.

Authors:  L Li; R Fu; T Zhang; X Xie; J Liu; J Tao; J Song; H Liu; W Zhang; W Lu; Z Shao
Journal:  Curr Oncol       Date:  2016-04-13       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.